BR0309019A - Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas - Google Patents

Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas

Info

Publication number
BR0309019A
BR0309019A BR0309019-1A BR0309019A BR0309019A BR 0309019 A BR0309019 A BR 0309019A BR 0309019 A BR0309019 A BR 0309019A BR 0309019 A BR0309019 A BR 0309019A
Authority
BR
Brazil
Prior art keywords
aspirin
treatment
antithrombotic
combination
diseases
Prior art date
Application number
BR0309019-1A
Other languages
English (en)
Inventor
Tony Verbeuren
Gilbert Lavielle
Bernard Cimetiere
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0309019A publication Critical patent/BR0309019A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"ASSOCIAçãO DE UM ANTITROMBóTICO E DE ASPIRINA, E SUA UTILIZAçãO PARA O TRATAMENTO DAS DOENçAS ATEROTROMBóTICAS". A presente invenção refere-se a uma nova associação de um atitrombótico e de aspirina, e as composições farmacêuticas que os contêm.
BR0309019-1A 2002-04-05 2003-04-04 Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas BR0309019A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine
PCT/FR2003/001054 WO2003084525A1 (fr) 2002-04-05 2003-04-04 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
BR0309019A true BR0309019A (pt) 2005-02-01

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309019-1A BR0309019A (pt) 2002-04-05 2003-04-04 Associação de um antitrombótico e de aspirina, e sua utilização para o tratamento das doenças aterotrombóticas

Country Status (27)

Country Link
US (1) US7618955B2 (pt)
EP (1) EP1496884B1 (pt)
JP (1) JP4065853B2 (pt)
KR (1) KR100645143B1 (pt)
CN (1) CN1297265C (pt)
AR (1) AR039253A1 (pt)
AT (1) ATE329591T1 (pt)
AU (1) AU2003246774B2 (pt)
BR (1) BR0309019A (pt)
CA (1) CA2480697A1 (pt)
CY (1) CY1105106T1 (pt)
DE (1) DE60306133T2 (pt)
DK (1) DK1496884T3 (pt)
EA (1) EA006978B1 (pt)
ES (1) ES2264533T3 (pt)
FR (1) FR2838057B1 (pt)
GE (1) GEP20074101B (pt)
HK (1) HK1076034A1 (pt)
MA (1) MA27114A1 (pt)
MX (1) MXPA04009760A (pt)
NO (1) NO20044700L (pt)
NZ (1) NZ535430A (pt)
PL (1) PL371620A1 (pt)
PT (1) PT1496884E (pt)
UA (1) UA79457C2 (pt)
WO (1) WO2003084525A1 (pt)
ZA (1) ZA200407593B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080017489A (ko) * 2005-07-22 2008-02-26 더 프록터 앤드 갬블 캄파니 약물 유발성 부정맥 발생률 감소용 조성물
KR101473207B1 (ko) * 2007-04-13 2014-12-16 밀레니엄 파머슈티컬스 인코퍼레이티드 Ｘａ 인자 억제제로서 작용하는 화합물과의 병용 항응고 요법
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HK1076034A1 (en) 2006-01-06
CA2480697A1 (fr) 2003-10-16
NZ535430A (en) 2006-09-29
DE60306133T2 (de) 2007-01-04
CN1646111A (zh) 2005-07-27
AU2003246774A1 (en) 2003-10-20
PL371620A1 (en) 2005-06-27
EA006978B1 (ru) 2006-06-30
MA27114A1 (fr) 2004-12-20
DE60306133D1 (de) 2006-07-27
AU2003246774B2 (en) 2007-02-15
EP1496884B1 (fr) 2006-06-14
WO2003084525A1 (fr) 2003-10-16
KR20040098053A (ko) 2004-11-18
JP4065853B2 (ja) 2008-03-26
CY1105106T1 (el) 2009-11-04
GEP20074101B (en) 2007-05-10
EA200401293A1 (ru) 2005-02-24
AR039253A1 (es) 2005-02-16
ES2264533T3 (es) 2007-01-01
MXPA04009760A (es) 2004-12-13
ZA200407593B (en) 2006-07-26
ATE329591T1 (de) 2006-07-15
US7618955B2 (en) 2009-11-17
KR100645143B1 (ko) 2006-11-10
DK1496884T3 (da) 2006-10-02
UA79457C2 (en) 2007-06-25
NO20044700L (no) 2004-10-29
US20050143354A1 (en) 2005-06-30
FR2838057B1 (fr) 2005-07-08
PT1496884E (pt) 2006-09-29
EP1496884A1 (fr) 2005-01-19
JP2005528376A (ja) 2005-09-22
CN1297265C (zh) 2007-01-31
FR2838057A1 (fr) 2003-10-10

Similar Documents

Publication Publication Date Title
BR9808998A (pt) Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
BRPI0413490A (pt) novos compostos
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
ES2179351T3 (es) Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores.
BRPI0515316A (pt) compostos de imidazoquinolina
BR0310092A (pt) Combinação de compostos orgânicos
BRPI0410746A (pt) compostos e composições imunossupressoras
ATE413167T1 (de) Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
BRPI0415683A (pt) inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
BR0207883A (pt) Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv
PA8638201A1 (es) Forma cristalina alfa del ranelato de estroncio procedimiento para su preparacion y composiciones farmaceuticas que la contienen
BR9702200A (pt) Compostos bicíclicos-aromáticos composição farmacéutica composição cosmética e utilização de uma composição cosmética
MXPA05013645A (es) Nuevos compuestos moduladores de los receptores de tipo ppar gama y su utilizacion en composiciones cosmeticas o farmaceuticas.
DE60330997D1 (de) Biaromatische verbindungen die ppar-gamma rezeptoren aktivieren und deren anwendungen in kosmetischen oder pharmazeutischen zusammensetzungen
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
BR9702144A (pt) Compostos propinil biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
BRPI0414299A (pt) composições farmacêuticas de liberação modificada de modafinil
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 8A E 9A ANUIDADES.